Literature DB >> 16842777

RNA quality and gene expression analysis of ovarian tumor tissue undergoing repeated thaw-freezing.

Kirsten Marie Jochumsen1, Qihua Tan, Jesper Dahlgaard, Torben A Kruse, Ole Mogensen.   

Abstract

Gene expression profiles evaluated by microarray-based quantization of RNA are used in studies of differential diagnosis and prognosis in cancer. RNA of good quality is mandatory for this evaluation. The RNA most often comes from tumor banks with limited amount of tissue, and the tissue often undergoes repeated thawing and freezing. We evaluated the influence of repeated division of tumor samples at room temperature, on RNA quality and quantity, in addition to the gene expression profile. Sixteen ovarian tumor samples were divided in three aliquots each, undergoing respectively one, two, and three thaw-freeze cycles. RNA from each aliquot was extracted on the day of division, and quantity and quality were evaluated. RNA from all three aliquots of four tumor samples underwent microarray analysis on Affymetrix Human Genome U133A 2.0 arrays. Microarray data were evaluated using both unsupervised, and supervised multivariate statistical methods, reliability analysis, as well as verification using published gene lists in ovarian cancer studies. RNA quality and quantity did not change during the division procedure and microarray data showed insignificant difference in gene expression. Tumor samples from tumor banks can be frozen and thawed at least three times without compromising the RNA integrity and genetic expression profile.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842777     DOI: 10.1016/j.yexmp.2006.05.004

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  7 in total

Review 1.  Quality assurance of RNA expression profiling in clinical laboratories.

Authors:  Weihua Tang; Zhiyuan Hu; Hind Muallem; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2011-10-20       Impact factor: 5.568

2.  Impact of RNA degradation on gene expression profiling.

Authors:  Lennart Opitz; Gabriela Salinas-Riester; Marian Grade; Klaus Jung; Peter Jo; Georg Emons; B Michael Ghadimi; Tim Beissbarth; Jochen Gaedcke
Journal:  BMC Med Genomics       Date:  2010-08-09       Impact factor: 3.063

Review 3.  The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings.

Authors:  Maryam Shabihkhani; Gregory M Lucey; Bowen Wei; Sergey Mareninov; Jerry J Lou; Harry V Vinters; Elyse J Singer; Timothy F Cloughesy; William H Yong
Journal:  Clin Biochem       Date:  2014-01-12       Impact factor: 3.281

4.  Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.

Authors:  Carissa F Santos; John Kurhanewicz; Z Laura Tabatabai; Jeffry P Simko; Kayvan R Keshari; Akpene Gbegnon; Romelyn Delos Santos; Scot Federman; Katsuto Shinohara; Peter R Carroll; Christopher M Haqq; Mark G Swanson
Journal:  NMR Biomed       Date:  2009-12-23       Impact factor: 4.044

5.  How to preserve and handle fish liver samples to conserve RNA integrity.

Authors:  Eeva-Riikka Vehniäinen; Maiju Ruusunen; Pekka J Vuorinen; Marja Keinänen; Aimo O J Oikari; Jussi V K Kukkonen
Journal:  Environ Sci Pollut Res Int       Date:  2019-04-22       Impact factor: 4.223

6.  Impact of Cold Ischemic Time and Freeze-Thaw Cycles on RNA, DNA and Protein Quality in Colorectal Cancer Tissues Biobanking.

Authors:  Xin-Juan Fan; Yan Huang; Pei-Huang Wu; Xin-Ke Yin; Xi-Hu Yu; Xin-Hui Fu; Li-Li Feng; Yun-Long Wang; Hong-Jun Yi; Zhi-Ting Chen; Jun-Xiang Yin; Da-Lu Zhang; Wei-Xing Feng; Shao-Mei Bai; Taewan Kim; Gordon B Mills; Yi-Ling Lu; Xiang-Bo Wan; Lei Wang
Journal:  J Cancer       Date:  2019-08-27       Impact factor: 4.207

7.  Clinical implementation of RNA signatures for pharmacogenomic decision-making.

Authors:  Weihua Tang; Zhiyuan Hu; Hind Muallem; Margaret L Gulley
Journal:  Pharmgenomics Pers Med       Date:  2011-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.